Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells

PURPOSE: Cisplatin-based chemotherapy is the first line treatment for several cancers including bladder cancer (BC). Autophagy induction has been implied to contribute to cisplatin resistance in ovarian cancer; and a high basal level of autophagy has been demonstrated in human bladder tumors. Theref...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ji-Fan, Lin, Yi-Chia, Tsai, Te-Fu, Chen, Hung-En, Chou, Kuang-Yu, Hwang, Thomas I-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439993/
https://www.ncbi.nlm.nih.gov/pubmed/28553083
http://dx.doi.org/10.2147/DDDT.S126464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439993/
https://www.ncbi.nlm.nih.gov/pubmed/28553083
http://dx.doi.org/10.2147/DDDT.S126464

Ejemplares similares